Intensifying competition, pricing pressure and copycat versions of Ozempic and Wegovy hold back sales at the pharma giant.
Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.
Novo Nordisk said on Wednesday it has accepted the U.S. Inflation Reduction Act (IRA)'s maximum fair price for its diabetes ...
Curvy Fashionista on MSN
Ozempic Praised As A Miracle Drug, But How Does It Affect Those With Eating Disorders
The Rise Of GLP-1 Drugs In just three years, drugs like Ozempic have reshaped how society views the body. They reignited a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback